Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

sectoralpha · stock story
Pharma - Formulators →
Home›Stocks›Accent Microcell Ltd
ACCENTMICAccent Microcell LtdPharma - Formulators
₹496+84.0% 1y

Accent Microcell Ltd (ACCENTMIC) — share price & stock analysis

Profits are up 47% in two years, most of that is already in the price.

STEADY GROWTH, FAIRLY PRICEDBeating NIFTY 500 for 44 weeks
STAGE 2 UPTRENDBEATING NIFTY 44W
COMPOUNDERNO REAL DEBT
DEEP CYCLICALEXPANSION
₹1,191 Cr
Market cap
27.2×
P/E
18.6%
ROE
64th pctile
vs own history (since 2024)
By Sector Alpha Research · machine-compiled from Screener.in data · Updated 1 July 2026 · Sources: Screener.in company page, NSE quote · Not investment advice
The 30-second answer

Accent Microcell Ltd (ACCENTMIC) trades at ₹496 as of 1 July 2026, up 84% over the past year — beating NIFTY 500 for 44 weeks. The machine reads this as steady growth, fairly priced: profits are up 47% in two years, most of that is already in the price. It trades at a P/E of 27.2× (the 64th percentile of its own range); the price is in Stage 2 — advancing, 51 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 62/100 (mostly improving).

Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.

Key numbers
Market cap
₹1,191 Cr
P/E
27.2×
ROE
18.6%
vs own history (since 2024)
64th pctile
Book value / share
₹115
EPS (TTM)
₹18.3
10-yr median P/E
20.0×
Revenue (FY26)
₹349 Cr
Profit after tax (FY26)
₹44 Cr
Weinstein stage
Stage 2 (51 weeks)
Data as of
1 July 2026
MOMENTUM OF THE FUNDAMENTALS
62/100
MOSTLY IMPROVING
Levels: ROCE 25% — a high-quality engine · effectively no debt · margins at an all-time high
SalesUp 51% YoY
MarginsOPM 16.7% → 15.6% in a year
ProfitUp 53% YoY
Cash generationOperating cash ₹25.0 Cr → ₹19.0 Cr
Balance sheetDebt is ₹0 per ₹100 of shareholders’ money
Committed ownersPromoters + funds hold 59.6% (a year ago: 57.3%)
DEEP CYCLICAL
Trough
Recovery
Expansion
Peak

Profits swing violently in this business — margins swinging 11 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit

Where the clock stands now: earnings sit at 100% of their historical range, margins are the best ever printed, and the market pays mid-range (64th percentile). That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit

4 of the 6 things we track are currently moving the right way — most of the dashboard is turning up.

Where the levels actually stand: ROCE 25% — a high-quality engine; effectively no debt; margins at an all-time high. Momentum says which way things are moving; these say where they are.

Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).

THE ONE CHART THAT MATTERS

Most of this rally is re-rating, not earnings

Since May 2024, the stock is up 60% while earnings per share grew 21%. The difference is re-rating — investors paying more for the same rupee of profit.pricettm_eps

That works until it doesn’t: from here, earnings have to do the lifting, because the multiple has already done its part.

Today’s P/E of 27.2× is the middle of its own range against its own history since 2024 (64th percentile) — neither a bargain nor a stretch, by its own standards.pe_ratio

Price, earnings per share, and the P/E the market pays₹ · ×valuation_history
20030040050014.016.0₹ price₹ EPS₹496EPS ₹18P/E ×20.030.0med 20×27×May 24Feb 25Dec 25Jul 26
Data: Price, EPS and valuation (sampled — full series in the embedded dataset)
PeriodPrice (₹)EPS (TTM) (₹)P/E (×)
May 24277–33.6
May 2425615.116.9
Jun 2426415.217.4
Jul 2428215.118.6
Aug 2426915.117.8
Aug 2426612.920.6
Sep 2426612.920.6
Oct 2426612.920.6
Oct 2424513.518.1
Nov 2422713.516.8
Dec 2425213.518.6
Dec 2425913.619.1
Jan 2525413.618.7
Feb 2524613.618.1
Feb 2520613.615.2
Mar 2519513.514.4
Apr 2519213.614.1
May 2519513.614.3
May 2523413.816.9
Jun 2522913.816.6
Jul 2527013.819.6
Jul 2527413.819.9
Aug 2529113.821.1
Sep 2527913.820.2
Sep 2524513.717.8
Oct 2528414.519.6
Nov 2528114.419.5
Nov 2532714.522.6
Dec 2533414.523.1
Jan 2635214.424.4
Feb 2633214.523.0
Feb 2632714.522.6
Feb 2633514.423.2
Mar 2634614.523.9
Apr 2638114.526.3
Apr 26434–30.0
Apr 26425–29.4
May 2643618.323.9
Jun 2647718.326.1
Jun 2645918.325.1
Jun 2646418.325.4
Jul 2649618.327.1

Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots (the window starts at the first stable snapshot — earlier IPO-era share-count revisions are excluded, since they are not earnings events); between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (20×).

WHERE THE PRICE IS IN ITS CYCLE

Stage 2: the trend is up, and has been for 51 weeks

STAGE 2 · ADVANCING · 51 WEEKS

Price trends have a life cycle: they base (1), advance (2), top out (3) and decline (4). This chart is in Stage 2: advancing — 51 weeks so far, confirmed.stage

The price sits above its rising 200-day average (₹370 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200

Beating NIFTY 500 for 44 weeks — relative strength is the market’s live opinion, and right now it is on this stock’s side.rs_mansfield

What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200

Weekly price with its 200-day and 50-day averages — stages shaded₹weinstein_stages
S4S4S2200300400500Price200-DMAStage 2 began · Aug 25Dec 23Nov 24Oct 25Jul 26
Data: Weekly price, moving averages and stage (sampled — full series in the embedded dataset)
PeriodPrice (₹)200-DMA (₹)50-DMA (₹)Stage
Dec 232982982984
Jan 243162962914
Jan 242882962934
Feb 242602922804
Mar 242602872714
Mar 242332812564
Apr 242492772544
May 242772752564
May 242562752664
Jun 242642742664
Jul 242822742694
Aug 242692742704
Aug 242662722664
Sep 242662712654
Oct 242662702654
Oct 242452682614
Nov 242272642514
Dec 242522612464
Dec 242592592484
Jan 252542602534
Feb 252462582514
Feb 252062532374
Mar 251952462204
Apr 251922392074
May 251952352064
May 252342312094
Jun 252292312184
Jul 252702332304
Jul 252742382494
Aug 252912462702
Sep 252792522792
Sep 252452532702
Oct 252842542652
Nov 252812562702
Nov 253272642882
Dec 253342743122
Jan 263522843272
Feb 263322903292
Feb 263352963292
Mar 263463013342
Apr 263813083432
Apr 264363233792
May 264413394082
Jun 264723524242
Jun 264613574312
Jun 264523634352
Jul 264963704442
THE LONG ARC

Profits have grown in 6 of the last 7 years — compounding so far, on a short record

Over 7 years, sales went from ₹114 Cr to ₹349 Cr (about 17% a year), and profit from ₹4.0 Cr to ₹44.0 Cr.revenuenet_profit

Margins widened 11 points along the way — growth with improving economics.operating_profit

Revenue by year₹ Crannual_results
0200FY19FY22FY25FY26
Data: Revenue by year
PeriodRevenue (₹ Cr)
FY19114
FY20131
FY21133
FY22166
FY23197
FY24246
FY25265
FY26349
Profit by year₹ Crannual_results
020.040.0FY19FY22FY25FY26
Data: Profit by year
PeriodProfit after tax (₹ Cr)
FY194
FY204
FY215
FY226
FY2312
FY2430
FY2533
FY2644
OPM % by year%annual_results
5.010.015.0FY19FY22FY25FY26
Data: OPM % by year
PeriodOPM % (%)
FY195.3
FY206.9
FY218.3
FY227.8
FY239.6
FY2415.9
FY2515.8
FY2616.3
CHAPTER 1 · THE ENGINE

Sales exploded 51% last quarter

Revenue — the money that comes in from customers, before any costs.

Mar 26 sales were ₹210 Cr, up 51% on the same quarter last year.revenue

Quarterly sales₹ Crquarterly_results
0100200YoY %+51Sep 23Sep 24Sep 25Mar 26
Data: Quarterly sales
PeriodRevenue (₹ Cr)YoY growth (%)
Sep 23107–
Mar 24139–
Sep 2412617.8
Mar 251390.0
Sep 2513910.3
Mar 2621051.1
WATCH →If quarterly growth slips below 26%, the story weakens.
CHAPTER 2 · THE TAKE

Margins have been rebuilt — 7.8% in FY22 to 16.3% now

Margins — the share of every ₹100 of sales kept as profit. Gross (after raw materials), operating (after running costs), net (after everything).

Of every ₹100 of sales, the company keeps ₹15.6 as operating profit (a year ago it kept ₹16.7).opm_pct

Zoom out and this is the page's quiet hero: annual operating margin bottomed at 7.8% in FY22 and has been rebuilt to 16.3% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit

The gross margin moved the same way (40% → 37%), so this is about input costs and pricing power — the raw-material equation worsened.gpm_pctopm_pct

Three margins, quarterly%margin_trends
10.020.030.040.0GrossOperatingNetMar 23Sep 24Mar 26
Data: Three margins, quarterly
PeriodGross (%)Operating (%)Net (%)
Mar 2332.614.812.0
Sep 2345.918.314.0
Mar 2436.514.411.6
Sep 2437.914.913.1
Mar 2539.916.712.0
Sep 2540.017.213.0
Mar 2636.915.612.3
CHAPTER 3 · THE BOTTOM LINE

Profit exploded 53% — mostly from selling more

PAT (profit after tax) — what is left for shareholders after every cost, interest and tax.

Mar 26 profit after tax was ₹26.0 Cr, up 53% year on year.net_profit

Quarterly profit after tax₹ Crquarterly_results
010.020.0YoY %+53Sep 23Sep 24Sep 25Mar 26
Data: Quarterly profit after tax
PeriodPAT (₹ Cr)YoY growth (%)
Sep 2314.0–
Mar 2416.0–
Sep 2416.014.3
Mar 2517.06.3
Sep 2518.012.5
Mar 2626.052.9
Where the profit change came from (Mar 25 → Mar 26)₹ Cr
17+12−2+1−1−126PAT Mar 25More salesThinnermarginsOther incomeDepreciationTaxPAT Mar 26

The single biggest driver was selling more.

Data: Where the profit change came from (Mar 25 → Mar 26)
ComponentEffect (₹ Cr)
PAT Mar 2517
More sales+12
Thinner margins−2
Other income+1
Depreciation−1
Tax−1
PAT Mar 2626
CHAPTER 4 · THE ACID TEST

Most of the profit becomes cash — but not all

Operating cash flow (CFO) — the cash that actually arrived, vs PAT, the profit accounting reports. Annual figures.

Over the last 5 profitable years, the business reported ₹125 Cr of profit and collected ₹78.0 Cr of operating cash — about 62% conversion.operating_cash_flownet_profit

The wrinkle is the latest year: FY26 collected ₹19.0 Cr against ₹44.0 Cr of reported profit — about 43%. One year isn’t a trend, but it is the line to watch.operating_cash_flownet_profit

The gap sits in receivables: customers now take 95 days to pay, up from 90. Profit booked, cash pending.debtor_days

Cash collected vs profit reported (annual)₹ Crcash_flow
20.040.0Operating cash flowProfit after taxFY19FY22FY25FY26
Data: Cash collected vs profit reported (annual)
PeriodOperating cash flow (₹ Cr)Profit after tax (₹ Cr)
FY196.04.0
FY205.04.0
FY215.05.0
FY2215.06.0
FY238.012.0
FY2411.030.0
FY2525.033.0
FY2619.044.0
CHAPTER 5 · THE PIPELINE

The cash cycle is stable

Working capital — days of sales locked up in inventory and unpaid bills. Screener reports this yearly, so this chart is annual.

One rupee now takes about 117 days to go out the door as materials and come back as collected cash — down from 124 days the year before.cash_conversion_cycle

The biggest mover: inventory moving faster off the shelf (76 → 55 days).inventory_days

Days of cash locked up (annual)daysratios
5075100125Customers owe (debtor days)Stock on shelf (inventory days)We owe suppliers (payable days)FY19FY22FY25FY26
Data: Days of cash locked up (annual)
PeriodCustomers owe (debtor days) (days)Stock on shelf (inventory days) (days)We owe suppliers (payable days) (days)
FY1970.067.089.0
FY2060.078.080.0
FY2135.012874.0
FY2238.012897.0
FY2356.0128106
FY2480.083.048.0
FY2590.076.042.0
FY2695.055.033.0
CHAPTER 6 · THE BUILD

Building hard — new capacity is under construction

Capex — money spent on plants, machines and buildings. Gross block is what exists; CWIP (capital work-in-progress) is what is being built. Annual.

The productive asset base has gone from ₹30.0 Cr (FY19) to ₹53.0 Cr, with another ₹102 Cr of capacity under construction right now.fixed_assetscwip

Work-in-progress is 192% of the existing asset base — that is a serious bet on future demand. Capacity like this shows up in sales with a lag; it is tomorrow’s growth being paid for today.cwip

The build is bigger than the cash engine: investing outflows (₹140 Cr) exceeded operating cash (₹55.0 Cr) over the last 3 years — the difference comes from debt or shareholders.investing_cash_flowoperating_cash_flow

Assets in place vs under construction (annual)₹ Crbalance_sheet
050.0100Fixed assetsUnder construction (CWIP)FY19FY22FY25FY26
Data: Assets in place vs under construction (annual)
PeriodFixed assets (₹ Cr)Under construction (CWIP) (₹ Cr)
FY1930.00.0
FY2029.00.0
FY2130.00.0
FY2230.00.0
FY2331.00.0
FY2429.02.0
FY2548.013.0
FY2653.0102
WATCH →When CWIP converts to assets, sales must follow — two years of rising assets with flat sales would mean the bet is not paying.
CHAPTER 7 · SURVIVAL

Almost no debt — this company cannot be killed by a bad year

Debt-to-equity — borrowings against shareholders’ money. Computed from the balance sheet. Annual.

For every ₹100 shareholders have put in (and left in), the company has borrowed ₹0 — total borrowings have shrunk from ₹32.0 Cr to ₹1.0 Cr over the window.borrowings

Total borrowings (annual)₹ Crbalance_sheet
010.020.030.0FY19FY22FY25FY26
Data: Total borrowings (annual)
PeriodBorrowings (₹ Cr)
FY1932.0
FY2030.0
FY2131.0
FY2224.0
FY2323.0
FY2413.0
FY252.0
FY261.0
Debt vs shareholders’ money (annual)xbalance_sheet
00.511.5FY19FY22FY25FY26
Data: Debt vs shareholders’ money (annual)
PeriodDebt ÷ equity (x)
FY191.5
FY201.2
FY211.2
FY220.8
FY230.5
FY240.1
FY250.0
FY260.0
CHAPTER 8 · THE ENGINE ROOM

Every ₹100 kept in the business now earns ₹25 — and the number is rising

ROCE — profit earned per ₹100 of capital used. ROE — the same, per ₹100 of shareholders’ money alone. Annual.

Return on capital employed is 25.0% (a year ago: 24.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct

Returns on capital (annual)%ratios
20.025.030.0ROCEFY20FY23FY26
Data: Returns on capital (annual)
PeriodROCE (%)
FY2018.0
FY2117.0
FY2219.0
FY2327.0
FY2431.0
FY2524.0
FY2625.0
CHAPTER 9 · WHO OWNS IT

Big money is quietly accumulating

Shareholding — who owns the company: founders (promoters), foreign funds (FII), domestic funds (DII).

Promoters hold 55.5%, essentially unchanged. Foreign funds own 0.6%, domestic funds 3.6%.promoters_pctfiis_pctdiis_pct

Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t.

Who holds the shares, quarterly%shareholding
Promoters55.1% → 55.5% · flat
55.155.255.355.455.5Mar 24Jun 25Mar 26
Foreign funds0.0% → 0.6% · up 0.5 pts
0.00.20.40.6Mar 24Jun 25Mar 26
Domestic funds1.6% → 3.6% · up 2.0 pts
2.03.0Mar 24Jun 25Mar 26
Data: Who holds the shares, quarterly
PeriodPromoters (%)Foreign funds (%)Domestic funds (%)
Mar 2455.10.01.6
Sep 2455.10.01.7
Mar 2555.10.02.2
Jun 2555.10.02.9
Sep 2555.40.03.3
Dec 2555.40.33.6
Mar 2655.50.63.6
WHAT IS NOT HAPPENING
  • Promoters are not selling. Their stake has moved 0.4 points or less in 7 quarters — it sits at 55.5%.promoters_pct
  • Foreign funds have neither piled in nor fled — their stake has held near 0.6% for 7 quarters. No smart-money signal, in either direction.fiis_pct
THE VERDICT

A good business — the question is the price

The numbers are genuinely mixed, and the price already assumes the good news continues.

Best thing in the data: debt improving (0.01× → 0×).borrowings

Biggest worry: free cash flow falling (₹16.0 Cr → ₹−30.0 Cr).operating_cash_flow

The machine committee — 7 independent readsON WATCH · 73%
Earnings patternPOSITIVE85% · w21
Valuation cyclePOSITIVE87% · w19
CatalystsNEGATIVE50% · w14
Quality & safetyNEUTRAL42% · w14
TechnicalsPOSITIVE39% · w12
ValuationPOSITIVE43% · w10
Growth at a pricePOSITIVE52% · w10
Business quality6.2/10
Management4.5/10
7-model research readON WATCH · 73% confidence
WHAT WOULD CHANGE THIS VIEWTwo quarters of profit reversing would kill this story.

Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.

More Pharma - Formulators stocks
Sun Pharmaceutical Industries LtdTorrent Pharmaceuticals LtdCipla LtdDr Reddys Laboratories LtdZydus Lifesciences LtdLupin LtdAll Pharma - Formulators stocks →
Frequently asked questions

Straight answers from the data

What does Accent Microcell Ltd do?

Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]. It is listed in the Pharma - Formulators sector with a market capitalisation of ₹1,191 Cr.

What is Accent Microcell Ltd's share price?

As of 1 July 2026, Accent Microcell Ltd trades at ₹496, up 84% over the past year, with a market capitalisation of ₹1,191 Cr. Beating NIFTY 500 for 44 weeks. Prices are weekly closes from Screener data; this page refreshes with each weekly update.

What is Accent Microcell Ltd's share price target?

Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Accent Microcell Ltd's intrinsic value at ₹692 per share under base assumptions (bear ₹293, bull ₹692), against the current price of ₹496 — a 50% margin of safety. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.

Is Accent Microcell Ltd stock overvalued or undervalued?

Accent Microcell Ltd trades at a P/E of 27.2× — the 64th percentile of its own 2.1-year trading range (median 20.0×), which is above the middle of its own historical range. Most of this rally is re-rating, not earnings. Since May 2024, the stock is up 60% while earnings per share grew 21%. The difference is re-rating — investors paying more for the same rupee of profit. Note the short 2.1-year valuation record.

What did Accent Microcell Ltd report in its latest quarterly results?

In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹210 Cr, up 51% on the same quarter last year. Mar 26 profit after tax was ₹26.0 Cr, up 53% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.

Is Accent Microcell Ltd growing?

Sales exploded 51% last quarter. Mar 26 sales were ₹210 Cr, up 51% on the same quarter last year.

Are Accent Microcell Ltd's profits growing?

Profit exploded 53% — mostly from selling more. Mar 26 profit after tax was ₹26.0 Cr, up 53% year on year.

What are Accent Microcell Ltd's operating margins?

Margins have been rebuilt — 7.8% in FY22 to 16.3% now. In the most recent quarter, of every ₹100 of sales, the company keeps ₹15.6 as operating profit (a year ago it kept ₹16.7).

What is Accent Microcell Ltd's long-term growth record?

Revenue grew from ₹114 Cr in FY19 to ₹349 Cr in FY26 — a 17.3% compound annual growth rate over 7 years. Profit after tax compounded at 40.9% over the same period (₹4 Cr → ₹44 Cr).

Is Accent Microcell Ltd stock in an uptrend?

Stage 2: the trend is up, and has been for 51 weeks. Accent Microcell Ltd is in Stage 2 — advancing, 51 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).

Why is Accent Microcell Ltd stock rising?

The price is up 84% over the past year, in a confirmed Stage 2 uptrend (51 weeks), and has beaten NIFTY 500 for 44 weeks. Since 2024, the price is up 60% while earnings per share moved 21%.

Is Accent Microcell Ltd beating the NIFTY 500?

Yes — beating NIFTY 500 for 44 weeks, as of 1 July 2026. Relative strength is measured weekly against the NIFTY 500 (Mansfield RS): a positive reading means the stock has outperformed the index over the trailing window, week after week.

Where is Accent Microcell Ltd in its business cycle?

The data reads Accent Microcell Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company, valuation at the 64th percentile. Profits swing violently in this business — margins swinging 11 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.

Who owns Accent Microcell Ltd — what is the promoter holding?

Promoters hold 55.5%, essentially unchanged. Foreign funds own 0.6%, domestic funds 3.6%. Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t. Shareholding is from Screener's quarterly filings data.

Does Accent Microcell Ltd have too much debt?

Almost no debt — this company cannot be killed by a bad year. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹0 — total borrowings have shrunk from ₹32.0 Cr to ₹1.0 Cr over the window.

What is the bull case for Accent Microcell Ltd?

Profits are up 47% in two years, most of that is already in the price. Best thing in the data: debt improving (0.01× → 0×). Sales exploded 51% last quarter.

What is the bear case for Accent Microcell Ltd — what could break the story?

Biggest worry: free cash flow falling (₹16.0 Cr → ₹−30.0 Cr). Two quarters of profit reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 26%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.

Is Accent Microcell Ltd a stock worth studying right now?

Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: a good business — the question is the price. The numbers are genuinely mixed, and the price already assumes the good news continues. Across the 7-model scorecard the composite research signal is on watch at 73% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.

Generated from Screener data · 12 sources · why_traces/1.0 + story/1.2
details
generated 2026-07-03 11:21 · 6 material moves detected
sources: screener_company_info, screener_quarterly_results, screener_annual_results, screener_valuation_history, screener_shareholding, screener_cash_flow, screener_ratios, screener_balance_sheet, screener_margin_trends, weinstein_stages, agent_scores, stock_timelines